These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9824816)
1. Inhibition of endometrial cancer cell lines by mifepristone (RU 486). Schneider CC; Gibb RK; Taylor DD; Wan T; Gerçel-Taylor C J Soc Gynecol Investig; 1998; 5(6):334-8. PubMed ID: 9824816 [TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570 [TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor A and c-Met mediates spheroids-endometrium attachment. Harduf H; Goldman S; Shalev E Reprod Biol Endocrinol; 2009 Feb; 7():14. PubMed ID: 19220894 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Reynolds RK; Hu C; Baker VV Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691 [TBL] [Abstract][Full Text] [Related]
5. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma]. Zhang G; Li XP; Wang JL; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125 [TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. El Etreby MF; Liang Y; Lewis RW Prostate; 2000 Apr; 43(1):31-42. PubMed ID: 10725863 [TBL] [Abstract][Full Text] [Related]
7. [Study on the treatment of high dose mifepristone and progesterone in endometrial carcinoma]. Li CZ; Wen ZQ; Lan SM; Wang JY; Liu Y Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):552-5. PubMed ID: 14680611 [TBL] [Abstract][Full Text] [Related]
8. A novel phenoxazine derivative suppresses proliferation of human endometrial adenocarcinoma cell lines, inducing G2M accumulation and apoptosis. Nakada T; Isaka K; Nishi H; Osakabe Y; Shimamoto T; Ohyashiki K; Tomoda A; Takayama M Oncol Rep; 2003; 10(5):1171-6. PubMed ID: 12883676 [TBL] [Abstract][Full Text] [Related]
9. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines. Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158 [TBL] [Abstract][Full Text] [Related]
10. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Cong L; Gasser J; Zhao J; Yang B; Li F; Zhao AZ Endocr Relat Cancer; 2007 Sep; 14(3):713-20. PubMed ID: 17914101 [TBL] [Abstract][Full Text] [Related]
11. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol. Di Simone N; Schneyer AL; Caliandro D; Castellani R; Caruso A Mol Cell Endocrinol; 2002 Jun; 192(1-2):187-95. PubMed ID: 12088879 [TBL] [Abstract][Full Text] [Related]
12. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a. Ma AY; Xie SW; Zhou JY; Zhu Y Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224 [TBL] [Abstract][Full Text] [Related]
13. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Dai D; Kumar NS; Wolf DM; Leslie KK Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185 [TBL] [Abstract][Full Text] [Related]
14. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines]. Lu Y; Liao QP; Chen CL; Yu L Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617 [TBL] [Abstract][Full Text] [Related]
15. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines. Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928 [TBL] [Abstract][Full Text] [Related]
16. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Bui TD; Zhang L; Rees MC; Bicknell R; Harris AL Br J Cancer; 1997; 75(8):1131-6. PubMed ID: 9099960 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium. Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186 [TBL] [Abstract][Full Text] [Related]
19. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines. Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391 [TBL] [Abstract][Full Text] [Related]
20. Role of estradiol receptor-alpha in differential expression of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H Arch Biochem Biophys; 1999 Aug; 368(1):31-9. PubMed ID: 10415108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]